These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2568133)

  • 1. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
    Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
    Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance ECT for treatment of therapy-resistant paranoid schizophrenia and Parkinson's disease.
    Höflich G; Kasper S; Burghof KW; Scholl HP; Möller HJ
    Biol Psychiatry; 1995 Jun; 37(12):892-4. PubMed ID: 7548464
    [No Abstract]   [Full Text] [Related]  

  • 3. Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: a case report.
    Hermesh H; Aizenberg D; Friedberg G; Lapidot M; Munitz H
    Biol Psychiatry; 1992 Feb; 31(4):407-11. PubMed ID: 1348431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
    Mukherjee S; Debsikdar V
    Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease].
    Höflich G; Burghof KW; Kasper S; Möller HJ
    Nervenarzt; 1994 Mar; 65(3):202-5. PubMed ID: 7909917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly.
    Sadananda SK; Holla B; Viswanath B; Narasimha A; Sebastian A; Math SB; Chandrashekar CR
    J ECT; 2013 Mar; 29(1):e6-7. PubMed ID: 23422531
    [No Abstract]   [Full Text] [Related]  

  • 7. Cigarette smoking and neuroleptic-induced parkinsonism.
    Decina P; Caracci G; Sandik R; Berman W; Mukherjee S; Scapicchio P
    Biol Psychiatry; 1990 Sep; 28(6):502-8. PubMed ID: 1977478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of drug-induced Parkinsonism by ECT.
    Ananth J; Samra D; Kolivakis T
    Am J Psychiatry; 1979 Aug; 136(8):1094. PubMed ID: 37749
    [No Abstract]   [Full Text] [Related]  

  • 9. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics.
    Prosser ES; Csernansky JG; Kaplan J; Thiemann S; Becker TJ; Hollister LE
    J Nerv Ment Dis; 1987 Feb; 175(2):100-5. PubMed ID: 2879880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-induced parkinsonism in older schizophrenics.
    Hoffman WF; Labs SM; Casey DE
    Biol Psychiatry; 1987 Apr; 22(4):427-39. PubMed ID: 2882787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW; White T
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
    Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
    J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices.
    Peralta V; Cuesta MJ; Caro F; Martinez-Larrea A
    Acta Psychiatr Scand; 1994 Nov; 90(5):354-7. PubMed ID: 7872040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
    Horiguchi J; Nishimatsu O
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R; Kay SR
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.
    Tugg LA; Desai D; Prendergast P; Remington G; Reed K; Zipursky RB
    Schizophr Res; 1997 May; 25(1):71-8. PubMed ID: 9176929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Electroconvulsive Therapy and Associated Cognitive Change in Schizophrenia: A Naturalistic, Comparative Study of Treating Schizophrenia With Electroconvulsive Therapy.
    Tor PC; Ying J; Ho NF; Wang M; Martin D; Ang CP; Tan C; Yap LS; Lu VJM; Simpson B; Mok YM; Loo C
    J ECT; 2017 Dec; 33(4):272-277. PubMed ID: 28640170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.